.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Fuji
Covington
Novartis
Cantor Fitzgerald
Deloitte
Cipla
Farmers Insurance
Federal Trade Commission
McKinsey

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,685,441

« Back to Dashboard

Which drugs does patent 8,685,441 protect, and when does it expire?


Patent 8,685,441 protects DEFINITY and is included in one NDA.

This patent has thirty-six patent family members in twenty-nine countries.

Summary for Patent: 8,685,441

Title:Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
Abstract: The present invention describes processes for the preparation of a lipid blend and a uniform filterable phospholipid suspension containing the lipid blend, such suspension being useful as an ultrasound contrast agent.
Inventor(s): Hui; Poh K. (Wellesley Hills, MA), Bishop; John E. (Groton, MA), Madrigal, Jr.; Eleodoro S. (Westford, MA)
Assignee: Lantheus Medical Imaging, Inc. (North Billerica, MA)
Application Number:13/949,105
Patent Claim Types:
see list of patent claims
Use; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Lantheus Medcl
DEFINITY
perflutren
INJECTABLE;INTRAVENOUS021064-001Jul 31, 2001RXYesYes► Subscribe► Subscribe METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,685,441

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,084,056Preparation of a lipid blend and a phospholipid suspension containing the lipid blend► Subscribe
9,545,457Preparation of a lipid blend and a phospholipid suspension containing the lipid blend► Subscribe
8,747,892Preparation of a lipid blend and a phospholipid suspension containing the lipid blend► Subscribe
8,658,205Preparation of a lipid blend and a phospholipid suspension containing the lipid blend► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,685,441

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina016444► Subscribe
Austria447976► Subscribe
Australia2115599► Subscribe
Australia746067► Subscribe
Brazil9907066► Subscribe
Canada2317921► Subscribe
China1191822► Subscribe
China1288373► Subscribe
Germany69941634► Subscribe
Denmark1419789► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
Johnson and Johnson
Fuji
McKesson
Cantor Fitzgerald
US Department of Justice
Farmers Insurance
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot